| Jaffrey, Samie (Weill Cornell Medicine 201810 Prof of Pharmacology + Co-Founder of Gotham Therapeutics) |
Professor |
Cornell University |
United States (USA) |
| Jafry, Syed (Thermo Fisher 201505 SVP + President Asia-Pacific + Emerging Markets) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
| Jager, Martin (BASF 201202 Global Head Animal Nutrition Business) |
President/Director/Head Business Group/Unit/Division |
BASF (Group) |
Germany |
| Jager, Ronald (PGS.Holland 201712 Managing Director) |
Managing Director |
PGS.Holland B.V. |
Netherlands |
| Jagiella, Manfred (Endress+Hauser 201711 Group Board Member responsible for analytical business) |
Board member, executive |
Endress+Hauser (Group) |
|
| Jagielski, Mike (KCR CRO 201309– CEO joined 201201 before Merck & Co) |
Chief Executive Officer (CEO) |
KCR CRO (Group) |
Poland |
| Jahn, Melanie (Analytik Jena 201708 Product Manager) |
product management |
Endress+Hauser (Group) |
Germany |
| Jain, Kewal |
n. a. |
Jain PharmaBiotech |
|
| Jakob, Uwe (Suppremol 200808 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Baxter (Group) |
Germany |
| Jakobsohn, Meir (Medison Pharma 201401 CEO + Founder) |
Chief Executive Officer (CEO) |
Medison Pharma (Group) |
Israel |
| Jaksch, Stefan (Ionicon 201003 Sales Engineer) |
Sales Manager / Marketing Manager |
Ionicon (Group) |
Austria |
| Jallal, Bahija (Immunocore 201901– CEO before AstraZeneca President MedImmune joined MedImmune 2006) |
Chief Executive Officer (CEO) |
Immunocore (Group) |
United Kingdom (GB) |
| Jamal, Waheed (Boehringer Ingelheim 201912 Corp VP + Head of CardioMetabolic Medicine) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| James, Alison (Coulter Partners 201712 Director PR + Marketing) |
Public Relations Manager / Investor Relations Manager |
Coulter Partners (The Coulter Partnership Ltd.) |
United Kingdom (GB) |
| James, David (Danaher 201404 SVP Diagnostics at Invetech) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| James, Desmond D. (Trophic Communications 202110) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Jaminet, Paul (Angiex 201708 CEO) |
Chief Executive Officer (CEO) |
Angiex Inc. |
United States (USA) |
| Jandrinitsch, Markus (Austria (govt) 202111 Investment Manager of aws Gründerfonds) |
Managing Director |
Austria (govt) |
Austria |
| Janezic, Marco J. (Eternygen 201407 Managing Director + 202207 Managing Director Life Science Factory) |
Managing Partner |
Eternygen (Group) |
Germany |
| Jankowsky, Rüdiger (Infarco 201510– Managing Director at Cinfa Biotech GmbH) |
Managing Director |
Infarco (Group) |
Germany |
| Janositz, Paul |
journalism |
|
|
| Jansen, Carin (LifeTecAachen-Jülich 201307 Managing Director) |
Cluster Manager |
LifeTecAachen Jülich e. V. |
Germany |
| Jansen, Katharina (Life Science Valley 202204– before Bayer) |
Cluster Manager |
Life Science Valley GmbH |
Germany |
| Jansen, Kathrin U. (Pfizer 201501 SVP + CSO Vaccine Research + Early Development) |
President/Director/Head Business Group/Unit/Division |
Pfizer (Group) |
United States (USA) |
| Jansen, Sven (Noventi 202202 Executive Board Member) |
Board member, executive |
Noventi (Group) |
Germany |
| Janssen, Egbert (Celsius79.com AG 201212 Vorstand) |
Board member, executive |
Celsius37.com AG |
Germany |
| Janssen, Gunnar (AMP Biosimilars 201505– CFO before AMP Supervisory Board Member + German Private Equity GmbH) |
Chief Financial Officer (CFO) |
AMP Biosimilars AG |
Germany |
| Janssen, Uwe (Miltenyi Biotec 201008 Business Development) |
Business Development Manager / Strategy Manager |
Miltenyi Biotec (Group) |
Germany |
| Janssens, Rogier (Merck (DE) 201901 Managing Director + General Manager Biopharma Business in China) |
Managing Director |
Merck (DE) (Group) |
Germany |
| Jantzen, Eckard (GALAB Laboratories GmbH 201203 Managing Director) |
Managing Director |
GALAB Technologies GmbH |
Germany |
| Jaquemar, Markus (BD 2013001– Business Director Diagnostics Central Europe before Anagnostics + Agilent + Beckman) |
Regional manager |
Becton, Dickinson (Group) |
Germany |
| Jardine, Ian (Thermo Fisher 200803 VP Global Research + Develop) |
Research & Development Manager |
Thermo Fisher (Group) |
United States (USA) |
| Jaskolski, Janik (Semalytix 201505– Managing Director + Co-Founder) |
Managing Director |
Semalytix GmbH |
Germany |
| Jazdowski, Oscar (SVB 202101 General Manager Silicon Valley Bank German Branch) |
General Manager (management) |
SVB (Silicon Valley Bank) (Group) |
Germany |
| Jean-Mairet, Joël (Ysios Capital 201206) |
n. a. |
Ysios Capital (Group) |
Spain (España) |
| Jeddeloh, Jeffrey A. (DNA Script 201811– VP BusDev + Commercial Strategy before Roche + Orion Genomics) |
Business Development Manager / Strategy Manager |
DNA Script (Group) |
United States (USA) |
| Jeffreys, Hayden (Lumora 2013– Commercial Director) |
Chief Commercial Officer (CCO) |
Erba Diagnostics Mannheim (Group) |
United Kingdom (GB) |
| Jegge, Gabriele (Medigene 201612 Investor + Public Relations) |
Public Relations Manager / Investor Relations Manager |
Medigene (Group) |
Germany |
| Jeggle, Helmut (STRÜNGMANN Group + before Hexal + scine 2009 Apceth Managing Director CFO) |
Investment Manager |
STRÜNGMANN Group (family Strüngmann) |
Germany |
| Jehle, Heinrich (3a-diagnostics 201910– Managing Director) |
Managing Director |
XPhyto Therapeutics (Group) |
Germany |
| Jehle, Regina (Abivax 201912– Director of Communications before BioNTech 2014– 2019) |
Public Relations Manager / Investor Relations Manager |
Abivax (Group) |
France |
| Jeker, Rene (Bruker Corp 201004 Managing Director Bruker BioSpin AG Switzerland) |
Managing Director |
Bruker (Group) |
Switzerland |
| Jekerle, Katherina (ResMed 202208– Managing Director of Mementor DE GmbH before ResMed Germany) |
Managing Director |
ResMed (Group) |
Germany |
| Jelic-Masterton, Gavin (Finox AG 201307– CEO joined 2/13 as SVP Marketing + Comercial before Ferring + Merck Serono) |
Chief Executive Officer (CEO) |
Finox AG (Finox Biotech) |
Switzerland |
| Jelich, Klaus (Bayer 201012 Site Manager Bayer Healthcare Wuppertal) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Jell, Jason (Sartorius 202110 Head of Marketing Communications Bioprocessing Division) |
Public Relations Manager / Investor Relations Manager |
Sartorius (Group) |
Germany |
| Jenckel, Ludolf (Atlas MAT) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
Germany |
| Jenkins, Annalisa (TransCelerate BioParma 201402 Chair of Board of Directors before Merck Serono + BMS) |
Research & Development Manager |
TransCelerate BioPharma Inc. |
United States (USA) |
| Jenkins, Richard (Silence Therapeutics 201806– Head of Clinical Development before Takeda + GSK + Roche) |
Chief Medical Officer (CMO) |
Silence Therapeutics (Group) |
United Kingdom (GB) |
| Jenn, Stephan (Novalix 201011 President) |
President/Director/Head Business Group/Unit/Division |
Novalix (Group) |
France |
| Jenne, Andreas (RSP Systems 201805– CEO before NEO New Oncology + Blackfield + Kinaxo) |
Chief Executive Officer (CEO) |
RSP Systems A/S |
Denmark |
| Jennewein, Amélie (Jennewein Biotechnologie GmbH Co-Founder) |
Company Founder |
Chr. Hansen (Group) |
Germany |
| Jennewein, Klaus (Jennewein Biotechnologie GmbH 201512 Managing Director + Co-Founder) |
Managing Director |
Chr. Hansen (Group) |
Germany |
| Jennewein, Stefan (Jennewein Biotechnologie GmbH Co-Founder) |
Company Founder |
Chr. Hansen (Group) |
Germany |
| Jenni, Mario (Bio-Technopark Schlieren 201104 Managing Director) |
Managing Director |
Bio-Technopark Schlieren-Zürich |
Switzerland |
| Jennings, Bryan (Noxxon 202111– CFO before Peptilogics + KAHR Bio + Beren Tx + Vista Capital Advisors + Morgan Stanley) |
Chief Financial Officer (CFO) |
Noxxon (Group) |
Netherlands |
| Jennings, Gary (Jado 2007 continued as CSO before co-founder + CEO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Jado Technologies GmbH |
Germany |
| Jennings, Lisa K. (CirQuest Labs 2008– CEO + Owner + Founder + Prof at Univ Tennessee Health Science Center) |
Chief Executive Officer (CEO) |
MLM Medical Labs (Group) |
United States (USA) |
| Jensen, Derek (Hamilton 201303 HPLC product specialist at Hamilton Company) |
Product Manager (personnel) |
Hamilton (Group) |
United States (USA) |
| Jensen, J. Chris (Speedel 200705 Head Scientific Affairs) |
n. a. |
Novartis (Group) |
Switzerland |
| Jensen, Jan Nygaard (Boehringer 202210 Global Head of Computational Biology + DIgital Sciences) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Jensen, Johannes (Novo Group 200501 VP of Novo Nordisk Biotech Fund) |
Investment Manager |
Novo Group (Group) |
Denmark |
| Jentner, Jürgen (HighQu GmbH 201504 Managing Director) |
Managing Director |
HighQu GmbH |
Germany |
| Jentsch, Stefan |
n. a. |
University of Heidelberg (Ruperto Carola) |
Germany |
| Jeradi, Ahmad (Adanced Technology Company 201207 VP Strategy Business Dev elopment / M&A International Operations) |
Business Development Manager / Strategy Manager |
Advanced Technology Company K.S.C. (ATC) |
Kuwait |
| Jessen, Timm-Heinrich (Topas Therapeutics 201510–202007 Managing Director before Bionamics + Scienamics RESIGNED 7/20) |
Managing Director |
Topas Therapeutics GmbH |
Germany |
| Ji, Darren (Elpiscience 201912 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Elpiscience Biopharma (CN) |
China |
| Jiali, Luo (Boehringer Ingelheim 201705 General Manager of BI Biopharmaceuticals (China) Co Ltd) |
General Manager (management) |
Boehringer Ingelheim (Group) |
China |
| Jiang, Frank (CStone 201905 CEO) |
Chief Executive Officer (CEO) |
CStone Pharmaceuticals (HKEX:2616) |
China |
| Jiang, Hui (BGI 202002 COO of MGI) |
Chief Operating Officer (COO) |
Sophia Genetics (Group) |
Switzerland |
| Jiang, Wei (Bayer 202008 EVP + President of Bayer Pharma Region China + APAC) |
Regional manager |
Bayer (Group) |
China |
| Jimenez, Joseph (Joe) (Novartis 201002–CEO before since 200704 CEO Consumer Health) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Switzerland |
| Joecker, Anika (CLC bio 201109 Bioinformatics Specialist) |
n. a. |
Qiagen (Group) |
Denmark |
| Johann, Peter (NGN Capital 200502 Managing General Partner) |
Managing Partner (investment firm) |
NGN Capital (Group) |
United States (USA) |
| Johannesson, Russ (Glooko 202201 CEO) |
Chief Executive Officer (CEO) |
Glooko (Group) |
United States (USA) |
| Johansen, Kenneth Graabek (2cureX 202102– CFO before JADBio + Raven Biosciences + Qiagen Aarhus + CLC bio) |
Chief Financial Officer (CFO) |
2cureX (Group) |
Sweden |
| John, Llewellyn (Nova Capital 200601 Accociated Partners before Deloitte) |
n. a. |
Nova Capital (Group) |
United Kingdom (GB) |
| Johnsen, Bent (Emperra GmbH 201706– Managing Director + CEO) |
Managing Director |
Emperra GmbH E-Health Technologies |
Germany |
| Johnson, Eric R. (JSR Corp 201706 President of JSR Life Sciences division) |
President/Director/Head Business Group/Unit/Division |
JSR Corporation (Group) |
Japan |
| Johnson, Jason (Illumina 201703 Senior Director for Arrays) |
Product Manager (personnel) |
Illumina (Group) |
United States (USA) |
| Johnson, Kevin Stuart (Medicxi Ventures 201602– General Partner before Index Ventures + PanGenetics + CAT) |
General Partner (venture partner) |
Medicxi Ventures (formerly Index Ventures Life Sciences) |
United Kingdom (GB) |
| Johnson, Noel L. (Sequana Medical 201404 CEO) |
Chief Executive Officer (CEO) |
Sequana Medical (Group) |
Switzerland |
| Johnson, Tim (TJ) (High Throughput Genomics 200811 CEO before Ventana Medical) |
Chief Executive Officer (CEO) |
Codetta Bio Inc. (Codetta Biosciences) |
United States (USA) |
| Johnson, Wendy (Gemini Advisors 201503 Managing Director before ProQuest Investments + Aires Pharmaceuticals) |
Managing Director |
|
|
| Johnson, Zoë (iOnctura 2018– promoted to CSO before UCB + Merck + Novimmune) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
iOnctura (Group) |
Switzerland |
| Johnstone, Craig (Evotec 201901– COO) |
Chief Operating Officer (COO) |
Evotec (Group) |
Germany |
| Jones, Jonathan (Waters 200403– Waters Manchester before Univ Swansea) |
Technical Manager |
Waters (Group) |
United States (USA) |
| Jones, Lee (Rebiotix 201804 CEO + Founder) |
Chief Executive Officer (CEO) |
Ferring (Paulsen Foundation) (Group) |
United States (USA) |
| Jones, Richard (Adrenomed 202203– CEO before Fusion Antibodies formerly Novartis + GSK + Genzyme + Shire) |
Chief Executive Officer (CEO) |
Adrenomed AG |
Germany |
| Jones, Richard (Shield Therapeutics 201105– CFO before Investec Investment Banking Director + Head of Healthcare) |
Chief Financial Officer (CFO) |
Iron Therapeutics (Switzerland) AG |
Switzerland |
| Jones, Steven C. (NeoGenomics 201703 EVP + Director Investor Relations) |
n. a. |
NeoGenomics (Group) |
United States (USA) |
| Jones, Trevor (Sigma-Aldrich 201412 VP Analytical business 200708 Euro Marketing Manager) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Jonischkeit, Barbara (BIOPRO 201504 Head of Communications) |
Public Relations Manager / Investor Relations Manager |
Baden-Württemberg (govt region) |
Germany |
| Joore, Jos (Mimetas 201410 CBO + Co-Founder) |
Chief Business Officer (CBO) |
Mimetas B.V. |
Netherlands |
| Joos, Thomas (NMI) |
n. a. |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Jordan, Alfons (Ionicon 201103– VP of Ionicon US Inc + co-founder of Ionicon Austria) |
President/Director/Head Business Group/Unit/Division |
Ionicon (Group) |
United States (USA) |
| Jordan, Andreas (MagForce 201110– interim CEO) |
Chief Executive Officer (CEO) |
MagForce (Group) |
Germany |
| Jordan, Foster (Charles River 201304 SVP Endotoxin + Microbial Detection) |
President/Director/Head Business Group/Unit/Division |
Charles River (Group) |
United States (USA) |
| Jordan, Pablo (Definiens 201310– VP Business Development Clinical Digital Pathology before bioMérieux + Ventana) |
Business Development Manager / Strategy Manager |
AstraZeneca (Group) |
Germany |
| Jordens, Jan (DSM 201606 at DSM Resolve) |
Laboratory Manager (industry) |
DSM (Group) |
Netherlands |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 32 33 34 ... 81 82 83 
![Picture [iito] No Content Marketing 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
